We are live on ! Find out more
Baupost Group

Baupost Group Portfolio holdings

AUM $5.05B Turnover 24%
1-Year Est. Return 13.05%
 

Baupost Group invests for the long term in companies and other investments it judges to be undervalued, on behalf of families, foundations, endowments and other institutions. Its philosophy puts risk management first. Seth Klarman, its chief executive and portfolio manager, founded it in 1982 with William Poorvu, a Harvard professor, and partners Howard Stevenson, Jordan Baruch and Isaac Auerbach, and the name is an acronym built from the founders' names. Poorvu supplied the first money to manage, which he had raised by selling his share in a local television station, and Seth Klarman's team ran it. Seth Klarman wrote a 1991 book on value investing, Margin of Safety.

This Fund
S&P 500
This Quarter Est. Return
+8.09%
1 Year Est. Return
+13.05%
3 Year Est. Return
+47.21%
5 Year Est. Return
+23.41%
10 Year Est. Return
+137.34%
AUM
$4.14B
AUM Growth
+$608M
Cap. Flow
+$456M
Cap. Flow %
11.01%
Top 10 Hldgs %
92.24%
Holding
23
New
4
Increased
4
Reduced
2
Closed
3
Avg Time Held
0.5 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.5 years

Sector Composition

Rank Sector Weight
1 Technology 50.31%
2 Healthcare 20.66%
3 Energy 14.76%
4 Miscellaneous 11.75%
5 Materials 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MU icon
1
Micron Technology
MU
$781B
$1.22B 29.54%
51,655,434
– –
2013 Q2
3 quarters
VSAT icon
2
Viasat
VSAT
$8.56B
$787M 19.02%
11,395,900
+266,700
+2% +$17.3M
2013 Q2
3 quarters
INVA icon
3
Innoviva
INVA
$1.31B
$641M 15.49%
25,695,899
+696,821
+3% +$20.4M
2013 Q2
3 quarters
LNG icon
4
Cheniere Energy
LNG
$60.3B
$313M 7.57%
+5,660,000
New +$271M
2014 Q1
0 quarters
IDIX
5
DELISTED
Idenix Pharmaceuticals
IDIX
$303M 7.32%
53,331,109
+16,420,241
+44% +$115M
2013 Q2
3 quarters
BP icon
6
BP
BP
$111B
$152M 3.68%
3,871,089
-3,056,368
-44% -$121M
2013 Q2
3 quarters
PBF icon
7
PBF Energy
PBF
$7.47B
$140M 3.38%
5,416,606
+3,440,000
+174% +$91.4M
2013 Q3
2 quarters
KERX
8
DELISTED
Keryx Biopharmaceuticals
KERX
$108M 2.6%
+6,310,850
New +$95.2M
2014 Q1
0 quarters
NG icon
9
NovaGold Resources
NG
$2.11B
$78.3M 1.89%
21,688,300
– –
2013 Q2
3 quarters
IMOS icon
10
ChipMOS TECHNOLOGIES
IMOS
$1.43B
$72.4M 1.75%
2,979,654
– –
2013 Q2
3 quarters
C.WS.A icon
11
DELISTED
Citigroup
C.WS.A
$66.9M 1.62%
104,246,007
– –
2013 Q2
3 quarters
RFMD
12
DELISTED
RF Micro Devices
RFMD
$51.9M 1.25%
+6,585,000
New +$40.5M
2014 Q1
0 quarters
TQNT
13
DELISTED
TriQuint Semiconductor
TQNT
$51.2M 1.24%
+3,825,000
New +$39.7M
2014 Q1
0 quarters
KIN
14
DELISTED
Kindred Biosciences
KIN
$51.2M 1.24%
2,763,848
-136,152
-5% -$2.6M
2013 Q4
1 quarter
ELOS
15
DELISTED
Syneron Medical
ELOS
$49.8M 1.2%
4,000,000
– –
2013 Q2
3 quarters
AOI
16
DELISTED
Alliance One International
AOI
$18.6M 0.45%
638,364
– –
2013 Q2
3 quarters
AIG.WS icon
17
DELISTED
AIG Warrants
AIG.WS
$13.4M 0.32%
656,443
– –
2013 Q2
3 quarters
TMQ icon
18
Trilogy Metals
TMQ
$317M
$6.76M 0.16%
5,005,298
– –
2013 Q2
3 quarters
AVEO
19
DELISTED
AVEO Pharmaceuticals
AVEO
$5.72M 0.14%
382,935
– –
2013 Q2
3 quarters
ALDW
20
DELISTED
Alon USA Partners LP
ALDW
$5.48M 0.13%
329,188
– –
2013 Q4
1 quarter
FNF icon
21
Fidelity National Financial
FNF
$11.6B
– –
-3,458,214
Closed -$64.1M –
TIVO
22
DELISTED
TiVo
TIVO
– –
-2,160,000
Closed -$42.5M –
ENZN
23
DELISTED
Enzon Pharmaceuticals
ENZN
– –
-4,337,858
Closed -$5.03M –

Similar funds

Baupost Group's Q1 2014 Portfolio in Review

As of Q1 2014, Baupost Group held 23 positions worth $4.14B, up 17% from $3.53B the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Baupost Group deployed $456M of net new capital in Q1 2014, opening 4 new positions and adding to 4 existing holdings. Its largest new stake was Cheniere Energy: 5,660,000 shares worth $313M.

By sector, the portfolio is most concentrated in Technology at 50% of assets, down from 53% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was BP, an estimated $121M trimmed.

  • Baupost Group's largest Q1 2014 buy was Cheniere Energy: 5,660,000 shares worth $313M.
  • Baupost Group added most to Idenix Pharmaceuticals in Q1 2014, an estimated $115M increase.
  • Baupost Group's biggest Q1 2014 reduction was BP, cutting an estimated $121M.
  • Baupost Group fully exited Fidelity National Financial in Q1 2014, selling an estimated $64.1M.
  • Baupost Group's ten largest holdings make up 92% of its $4.14B portfolio in Q1 2014.
  • Baupost Group opened 4 new positions and closed 3 in Q1 2014.
  • Baupost Group's portfolio value rose 17% quarter-over-quarter to $4.14B.

Based on Baupost Group's 13F filing for Q1 2014, filed 14 May 2014.